German scientists have found novel coronavirus can also be transmitted in patients with mild symptoms.
-
Last Update: 2020-02-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In a new study, from charit é - Universit ä tsmedizin Novel coronavirus (2019-nCoV) was also isolated from patients with mild symptoms, and Berlin, Schwaben and the Munich clinic of the German Federal Defense Force found that even infectious nasopharyngeal swabs were obtained from patients with mild symptoms They therefore concluded that even patients with mild symptoms can spread the virus Since the first case of 2019 ncov infection was confirmed in Germany, the Institute of Virology, School of medicine, University of Charlotte, Berlin, and the Institute of Microbiology, Bundeswehr, have been supporting the diagnosis The two institutes operate independently of each other and regularly monitor virus shedding in patients currently being treated at the Schwab clinic in Munich In the course of these studies, the researchers found that in several cases, infectious 2019 ncov virus was isolated from nasopharyngeal swab samples obtained from patients with mild symptoms, and the virus was able to replicate in cell cultures The symptoms of these patients are the first to remind people of the common cold rather than severe pneumonia Novel coronavirus 2019-nCoV is not only replicated in the lungs but also in the nose, throat and intestines, and the research carried out by the two institutes also found evidence Their comprehensive observation shows that even patients with mild or early symptoms of cold (sore throat, signs of sinusitis, mild discomfort without fever) can transmit the virus The study was led by Professor Christian drosten, director of the Institute of Virology, School of medicine, University of Charlotte, Berlin, Dr Roman w ö lfel of the German Bundeswehr Institute of Microbiology and Professor Clemens wendtner, head of the Department of infectious diseases and tropical medicine, schwabin clinic, Munich For the school of medicine at the University of sharit in Berlin, it is important to publish the latest findings for 2019 ncov without delay The findings of these researchers have been reported to the Robert Koch Institute and permanent working group of medical competence and treatment centers for high consequence infectious diseases in Germany Their data are being published in a scientific journal.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.